Previous Article | Next Article 
Infection and Immunity, December 2001, p. 7271-7276, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7172-7276.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differences in Innate Defense Mechanisms in
Endotoxemia and Polymicrobial Septic Peritonitis
Bernd
Echtenacher,1
Marina A.
Freudenberg,2
Robert S.
Jack,3 and
Daniela N.
Männel3,*
Max-Planck-Institute for Immunobiology,
Freiburg,1 Institute for Immunology,
University of Greifswald, Greifswald,2 and
Institute for Pathology/Tumor Immunology, University of
Regensburg, Regensburg,3 Germany
Received 8 June 2001/Returned for modification 13 July
2001/Accepted 20 August 2001
 |
ABSTRACT |
Loss, reduction, or enhancement of the ability to respond to
bacterial lipopolysaccharide (LPS) has no influence on survival of mice
in a model of postoperative polymicrobial septic peritonitis induced by
cecal ligation and puncture (CLP). This was demonstrated by using
either mice with a defective Tlr4 gene, which encodes the critical receptor molecule for LPS responses, or mice deficient for
LPS binding protein (LBP) or mice sensitized to LPS by
Propionibacterium acnes. Though interleukin-12 (IL-12)
and gamma interferon (IFN-
) play an important role in the
sensitivity to LPS as well as in the resistance to several infections,
loss of these cytokine pathways does not affect survival after CLP.
Thus, neutralization of neither endogenous IL-12 nor IFN-
altered
mortality. In addition, IFN-
receptor-deficient mice demonstrated
the same sensitivity to CLP as mice with a functional IFN-
receptor.
However, administration of IFN-
at the time of operation or
pretreatment of both IFN-
-sensitive and IFN-
-resistant mice with
IL-12 significantly enhanced mortality. This indicates that in the
present infection model activation of innate defense mechanisms is not
dependent on LPS recognition and does not require endogenous IL-12 or
IFN-
function. Indeed, exogenous application of these two mediators
had deleterious effects.
 |
INTRODUCTION |
During septic peritonitis
gram-negative and gram-positive bacteria are transported via lymphatics
and blood into vital organs. Lipopolysaccharide (LPS) is an important
target molecule for recognition of gram-negative bacteria by the innate
immune system and a widely used model substance which, depending on the
dose, causes inflammation, shock, or death (7). LPS
binding protein (LBP) is a plasma protein that accelerates binding of
LPS to CD14 and thereby considerably enhances the host's sensitivity
to LPS (23). Thus, the host perceives minute
concentrations of LPS, which normally indicate a bacterial infection,
and can mount an antibacterial response while the infection is still at
an early stage. Inactivation of the LBP gene reduces the susceptibility
of mice to LPS and increases their susceptibility to a Salmonella
enterica serovar Typhimurium infection (12).
Similarly, mutation or deletion of the Tlr4 gene which
results in LPS unresponsiveness (22, 27) leads to a high
susceptibility to infection with S. enterica serovar Typhimurium (21, 29) and encapsulated Escherichia
coli (2).
The cytokines interleukin-12 (IL-12) and gamma interferon (IFN-
) are
important mediators of innate immune reactions, and both are released
after bacterial infection or challenge with LPS. In a number of
bacterial infection models survival or clearance of pathogens either
requires IFN-
or IL-12 or is enhanced when these cytokines are
administered exogenously. IL-12 neutralization impaired the clearance
of intraperitoneally (i.p.) instilled E. coli
(33) and inhibited resistance against Yersinia
enterocolitica (1), whereas treatment with IL-12
before or after infection with streptococci increased survival
(19). Survival in a model of septic peritonitis (colon
ascendens stent peritonitis [CASP]) required IFN-
receptor
(IFN-
R) activation (31), and IL-12 frequently exerts
its protective effects through induction of IFN-
(1,
32). Both cytokines, however, contribute to mortality after
lethal LPS challenge, as demonstrated in mice pretreated with
Propionibacterium acnes (5, 6) or infected with
Mycobacterium bovis BCG (30). Recently, mice
pretreated with P. acnes were shown to be highly sensitive
to high-dose S. enterica serovar Typhimurium infection (M. Gumenscheimer and M. A. Freudenberg, unpublished data).
These findings raised the question of how LPS-insensitive (TLR4-
and LBP-deficient) or LPS-hypersensitive (P. acnes-primed) mice would react in a more complex, clinically relevant model of septic
peritonitis induced by cecal ligation and puncture (CLP). After CLP a
postoperative, mixed, bacterial septic peritonitis, characterized by a
septic focus and a protracted course of systemic infection, develops.
The host becomes exposed to the whole range of intestinal flora,
including gram-negative bacteria. Therefore, survival after CLP was
expected to be improved by endogenous or exogenous IL-12 or IFN-
.
Surprisingly, however, we found that survival after CLP was not
affected by loss of TLR4 or LBP, the presence of endogenous
IL-12 or endogenous IFN-
, or sensitization with P. acnes but was decreased by treatment with IL-12 or IFN-
.
 |
MATERIALS AND METHODS |
Mice.
Male NMRI mice (25 to 30 g) were purchased from
Charles River (Sulzfeld, Germany). IFN-
R-deficient
(IFN-
R
/
) mice (129/Sv) (11),
LPS-nonresponder BALB/c/l mice carrying the mutated Tlr4
gene of C3H/HeJ mice (26), and the respective control mice
were bred in the animal facilities of the Max-Planck-Institut für
Immunbiologie (Freiburg, Germany). LBP-deficient
(LBP
/
) mice and their heterozygous
littermates (12) were bred in the Institut für
Immunologie (Greifswald, Germany).
CLP.
Mice were anesthetized by i.p. injection of 75 mg of
Ketanest (Parke, Davis & Company, Münich, Germany)/kg of body
weight and 16 mg of Rompun (Bayer AG, Leverkusen, Germany)/kg in 0.2 ml
of sterile pyrogen-free saline (Fresenius AG, Bad Homburg, Germany).
The cecum was exteriorized, and the distal end of the cecum (about 30%
of the total cecal length for sublethal CLP and 70% for lethal CLP)
was ligated and punctured once or twice (depending on the intended
lethality) with a 0.9-mm-diameter needle as described previously
(3). Mice were observed for 2 weeks.
Reagents.
Recombinant mouse IL-12, kindly donated by M. Gatley (Hoffman LaRoche Inc., Nutley, N.J.), was injected i.p. as
indicated above or after CLP. Recombinant mouse IFN-
was kindly
donated by G. R. Adolf (Bender GmbH, Vienna, Austria), and 1 µg
was injected i.p. immediately after CLP. P. acnes (strain
ATCC 12930; American Type Culture Collection, Manassas, Va.) was grown
and killed as described previously (13). For pretreatment
with P. acnes mice were injected intravenously (i.v.) with
25 µg of heat-killed P. acnes/g 7 days before CLP. LPS W
from Salmonella enterica serovar Minnesota 9700 was
purchased from Difco Laboratories (Detroit, Mich.).
For neutralization of IFN-
mice received 100 µg of protein
A-purified rat anti-mouse IFN-
monoclonal antibody R4-6A2
(24) i.p. immediately after CLP. To neutralize IL-12, mice
received 1 ml of rabbit anti-mouse IL-12 antiserum (8)
i.p. immediately after the operation. Control mice received 1 ml of
normal rabbit serum. All sera were complement inactivated. The in vivo
neutralization capacity of the antibody preparations has been
demonstrated previously (8).
Quantitation of tumor necrosis factor (TNF) serum titers and IFN-
serum titers was done using the bioassays for mouse TNF (3) and IFN (16), respectively, as described earlier.
 |
RESULTS |
Role of LPS sensitivity in septic peritonitis.
We compared the
mortality of LPS-sensitive mice with that of LPS-resistant mice after
CLP. BALB/c/l mice (26) are highly resistant to LPS due to
a point mutation in the intracellular domain of TLR4, which is critical
for transducing LPS responses (22). The sensitivity of
these mice to CLP as measured by the mortality was not different from
that of mice with normal LPS responsiveness (Fig.
1).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Mortality after CLP was not affected by TLR4 deficiency.
BALB/c mice (n = 15) and BALB/c/l mice
(n = 15) were subjected to CLP and mortality was
recorded (P < 0.12; log rank statistic).
|
|
Furthermore, ablation of the gene for LBP, a molecule which facilitates
LPS responses (12), did not alter the mortality in the CLP
procedure (Fig. 2).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Mortality after CLP was not influenced by LBP gene
deficiency. LBP / mice (n = 11) and
LBP+/ mice (n = 11) were subjected to
sublethal CLP, and LBP / mice (n = 9) and LBP+/ mice (n = 11) were
subjected to lethal CLP. Mortality was recorded (P < 0.39 for sublethal CLP and P < 0.29 for lethal
CLP; log rank statistic).
|
|
Role of IL-12 in septic peritonitis.
IL-12 has been shown on
one hand to enhance mortality in LPS-induced shock (30)
and on the other hand to be protective in a number of infection models
(33). To determine whether endogenous IL-12 contributes to
survival of mice after CLP-induced septic peritonitis, IL-12 was
neutralized by treating mice with anti-IL-12 antiserum immediately
after the operation. As can be seen in Fig. 3, there was no significant change in
mortality due to this anti-IL-12 treatment, which has been shown in
other experiments to effectively neutralize IL-12 in vivo
(8).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
Neutralization of IL-12 did not change survival after
CLP. Groups of NMRI mice (n = 10) received either
rabbit anti-IL-12 antiserum or normal rabbit serum immediately after
CLP. Mortality was recorded (P < 0.46; log rank
statistic). Ig, immunoglobulin.
|
|
Because exogenous IL-12 has been found to protect hosts from infections
(19), we treated mice with recombinant IL-12 (rmIL-12). Administration of 10 to 100 ng of rmIL-12 immediately after CLP did not
influence the outcome of CLP (Table 1).
However, mice became more sensitive to CLP and the mortality increased
when the animals were treated with 30 or 100 ng of rmIL-12 1 day prior to the operation or with 1 µg of rmIL-12 given two times before CLP.
In mice pretreated in this way twice with 1 µg of rmIL-12, a low
nonlethal dose of bacterial LPS induced IFN-
production. Compared to
results for nonpretreated animals the IL-12 treatment led to serum
IFN-
titers that were more than 10-fold enhanced (Table
2) 3 h after LPS injection. The
pretreatment with rmIL-12 also enhanced LPS-induced TNF serum levels
very strongly. Thus, rmIL-12-pretreated mice exhibited enhanced
sensitivity to LPS and were more sensitive to CLP.
Role of IFN-
in septic peritonitis.
To test whether IFN-
is involved in the resistance to CLP-induced septic peritonitis, we
compared the mortality of IFN-
R
/
mice and
that of the respective wild-type (wt) mice in this model. As shown in
Fig. 4b the
IFN-
R
/
mice showed no change in mortality
after CLP in comparison to control animals. Therefore we conclude that
endogenous IFN-
production is not essential for controlling the
development of septic peritonitis after CLP. This was confirmed by the
finding that neutralization of endogenously produced IFN-
after CLP
did not affect the outcome of CLP (Fig.
5).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
No sensitization for CLP lethality by P.
acnes pretreatment in normal or in IFN- R /
mice. (a) Groups of IFN- R / mice and normal 129/Sv
mice (n = 8) received either P.
acnes or phosphate-buffered saline i.v. Seven days later a CLP
of higher lethality was performed (P > 0.09 for
each comparison of two Kaplan-Meier curves; log rank statistic).
(b) Groups of IFN- R / mice and normal 129/Sv mice
(n = 8) received P. acnes (25 µg
i.v.). Seven days later a CLP of low lethality was performed. Mortality
was recorded (P < 0.8; log rank statistic).
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Postoperative neutralization of IFN- did not
influence CLP lethality. Immediately after CLP of low lethality, groups
of NMRI mice (n = 8) received either normal rat
immunoglobulin G (IgG) or rat anti-mouse IFN- monoclonal antibody
R4-6A2 (100 µg per mouse i.p.). Mortality was recorded
(P < 0.9770; log rank statistic).
|
|
As shown above, pretreatment of mice with rmIL-12 enhanced mortality
after CLP. IL-12 is a potent inducer of IFN-
(1, 32).
However, it is shown in Fig. 6 that
pretreatment of IFN-
R
/
mice with rmIL-12
also enhanced lethality after CLP. This indicates that IFN-
plays no
role in the enhanced susceptibility to septic peritonitis induced by
IL-12. However, administration of 1 µg of recombinant IFN-
(rmIFN-
) at the time of the operation significantly enhanced
mortality in wild-type mice. This could be seen both after sublethal
CLP (Fig. 7a) and after CLP which led to
40% lethality (Fig. 7b). The amount of IFN-
injected was not lethal
per se for uninfected mice (data not shown).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 6.
Increased CLP susceptibility caused by IL-12
pretreatment did not depend on the IFN- R. Groups of
IFN- R / mice (n = 10) and normal
129/Sv mice (n = 7) received either rmIL-12 (100 ng
per mouse) or phosphate-buffered saline (PBS) 24 h before CLP i.p.
Mortality was recorded (P < 0.0014 for
IFN- R / and IL-12 versus IFN- R /
and PBS, and P < 0.0009 for normal 129/Sv mice
treated with IL-12 versus normal 129/Sv mice treated with PBS; log rank
statistic).
|
|

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 7.
Postoperative administration of IFN- increased CLP
lethality. (a) Immediately after sublethal CLP, groups of NMRI mice
(n = 5) received either phosphate-buffered saline
(PBS) or rmIFN- (1 µg per mouse i.p.). Mortality was recorded
(P < 0.049; log rank statistic). (b) Immediately
after CLP of low lethality, groups of NMRI mice (n = 5) received either PBS or rmIFN- (1 µg per mouse i.p.).
Mortality was recorded (P < 0.004; log rank
statistic).
|
|
Bacterium-induced IL-12 production and the subsequent IFN-
response
are the essential events involved in the sensitization of mice by
P. acnes to LPS (5, 6) and some (but not all) of the other biologically active components of gram-negative and gram-positive bacteria (18). In this study we compared the
sensitivities of P. acnes-primed and unprimed wild-type and
IFN-
/
mice to CLP. Surprisingly, no
difference in susceptibility to CLP-caused death between control and
sensitized mice and between wild-type and IFN-
R-deficient mice was
observed, regardless of the severity of the CLP performed (Fig. 4).
 |
DISCUSSION |
The protective function of IL-12 and IFN-
in a number of
infection models has been reported (1, 32, 33), and
impaired IL-12 production was correlated with increased susceptibility to postoperative sepsis in patients (10). At the same time
IL-12 and IFN-
have been found to be deleterious in LPS-induced
shock (5, 30) or after high-dose infection with
gram-negative bacteria (Gumenscheimer and Freudenberg,
unpublished data). We therefore attempted to clarify the role of IL-12
and IFN-
in a clinically relevant model of sepsis. The response to
CLP, a model of a postoperative mixed sepsis, is clearly independent of
the activation of the innate immune system via LPS, the principal
endotoxic molecule from the outer cell walls of gram-negative bacteria.
Mice (BALB/c/l) in which the sensing of LPS, and thus of gram-negative
bacteria, is impaired were as sensitive in this CLP model as
LPS-competent mice. This finding is in full agreement with the report
of Mercer-Jones et al. (17), who obtained the same results
with C3H/HeJ mice, which have the identical genetic defect.
Furthermore, the fact that the presence or absence of LBP did not alter
the outcome after CLP also indicated that the capacity to sense LPS as
a danger molecule during infection with gram-negative bacteria
(9) does not seem crucial for survival in this model. Even
though gram-negative bacteria constitute part of the infection after
CLP (28), it seems clear that constituents other than LPS
dominate the initiation of the innate immune responses essential for
localization of the septic focus and the induction of effective
antibacterial mechanisms (4). In agreement, a strong
enhancement of LPS susceptibility in mice by P. acnes did in
no way influence the experimental outcome after CLP in this study. This
is remarkable, since pretreatment with P. acnes does not
sensitize animals to LPS and, thus, to gram-negative bacteria only. As
shown recently, the pretreatment of mice with P. acnes
increased the susceptibility to a not yet identified component of
gram-positive Listeria monocytogenes and to a
macrophage-activating lipopeptide (MALP-2) of Mycoplasma spp. (18).
Keeping in mind that LPS is not the key molecule determining survival
after CLP, the relevant mechanisms for survival remain to be
determined. Obviously, these mechanisms are different from those
induced by LPS. Clearly, IFN-
R activation is not critical for
survival in CLP-induced septic peritonitis. This is in sharp contrast
to the situation after infection with several other microbial organisms. It is also in contrast with the finding of the protective role of IFN-
in a different septic peritonitis model, called CASP
(31). The explanation for the different IFN-
requirements in the two peritonitis models with mixed bacterial
infection might have its roots in the critical need for abscess
formation after CLP in order to localize the septic focus
(4). In contrast to the largely localized inflammatory
response after CLP, a systemic response after CASP, which more
closely resembles that developing after challenge with LPS, may be
involved in survival. The differences between the systems is emphasized
by the fact that, far from reducing mortality, exogenous application of
IFN-
directly after CLP was actually deleterious in our experiments,
which is in agreement with the findings of Miles et al.
(20).
IL-12 did not exert any protective effect in CLP-induced septic
peritonitis. This is surprising in the light of the findings by
Steinhauser et al. (25), who found that neutralization of endogenous IL-12 prevented the organization of the damaged cecum wall
after CLP, and of the results from a study in which IL-12 treatment
increased resistance of mice to a streptococcal skin infection
(19). As shown here, IL-12 pretreatment, particularly after repeated bolus injection, had a rather deleterious effect in our
model. The effect of IL-12 pretreatment in this study is suggestive of
a sustained systemic inflammatory response which might contribute to
toxicity (14). Our results show that the enhanced
mortality after IL-12 pretreatment is not due to the endogenous
production of IFN-
. It is, however, entirely possible that enhanced
LPS-elicited TNF induced by IL-12 pretreatment could contribute to the
observed enhanced sensitivity. TNF has clearly been shown to be
critically required for survival after CLP (3), but, at
the same time, CLP-induced septic peritonitis makes mice exquisitely
sensitive to TNF (15). The mechanism by which IL-12 and
IFN-
enhance mortality after CLP is not known and has to be
elucidated in future studies. In this respect it is interesting that
treatment of mice with P. acnes, which is known to induce elevated, long-lasting IL-12 and IFN-
production, did not exert any
deleterious effect in our infection model. It is possible that some
positive, not yet identified effects of P. acnes treatment mask the negative effects of the above cytokines in the CLP model.
Over the years experiments with LPS have provided a large amount of
valuable information on the mechanisms that the innate immune system
sets in motion to mount an inflammatory reaction. However, since
different pathogens employ very different strategies, it is clear that
the host must be able to respond in ways optimized to combat each
infecting agent depending on the infection route. No single host
response will be able to cover all eventualities, and in this sense it
is not surprising that different receptors and cytokine pathways seem
to be crucial for survival in different modes of infection. CLP
initiates a response more complex than that resulting from LPS or from
infection with a single bacterial species. This clinically relevant
polymicrobial infection may induce a wide range of innate immune
mechanisms with overlapping effects. In this complex mixture each
bacterial species may act as an adjuvant for the others. In this sense
it is not altogether surprising that there is no discernible effect of
disabling individual elements of the innate immune system (LBP, TLR4,
IL-12, or IFN-
R). Following this line of thought, we tested whether
sensitization with P. acnes would not perhaps also provide
such an adjuvant effect. That this did not occur, although direct
application of IFN-
or of IL-12 did have a dramatic effect, may
simply reflect the importance of carefully regulated cytokine responses
in complex infections and in sepsis.
 |
ACKNOWLEDGMENT |
This work was supported by BMBF grant 01KI9853/5.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Pathology/Tumor Immunology, University of Regensburg,
F.-J.-Strauss-Allee, D-93042 Regensburg, Germany. Phone:
49.941.944-6622. Fax: 49.941.944-6602. E-mail:
daniela.maennel{at}klinik.uni-regensburg.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Bohn, E., and I. B. Autenrieth.
1996.
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
J. Immunol.
156:1458-1468[Abstract].
|
| 2.
|
Cross, A. S.,
J. C. Sadoff,
N. Kelly,
E. Bernton, and P. Gemski.
1989.
Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
J. Exp. Med.
169:2021-2027[Abstract/Free Full Text].
|
| 3.
|
Echtenacher, B.,
W. Falk,
D. N. Männel, and P. H. Krammer.
1990.
Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.
J. Immunol.
145:3762-3766[Abstract].
|
| 4.
|
Echtenacher, B.,
K. Weigl,
N. Lehn, and D. N. Männel.
2001.
Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice.
Infect. Immun.
69:3550-3555[Abstract/Free Full Text].
|
| 5.
|
Freudenberg, M.,
M. Kopf, and C. Galanos.
1996.
Lipopolysaccharide sensitivity of interferon-gamma receptor deficient mice.
J. Endotoxin Res.
3:291-295.
|
| 6.
|
Galanos, C., and M. A. Freudenberg.
1993.
Mechanisms of endotoxin shock and endotoxin hypersensitivity.
Immunobiology
187:346-356[Medline].
|
| 7.
|
Galanos, C.,
M. A. Freudenberg,
O. Luderitz,
E. T. Rietschel, and O. Westphal.
1979.
Chemical, physicochemical and biological properties of bacterial lipopolysaccharides.
Prog. Clin. Biol. Res.
29:321-332[Medline].
|
| 8.
|
Hafner, M.,
W. Falk,
B. Echtenacher, and D. N. Männel.
1999.
Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Eur. Cytokine Netw.
10:541-548[Medline].
|
| 9.
|
Heinrich, J.-M.,
M. Bernheiden,
G. Minigo,
K. K. Yang,
C. Schütt,
D. N. Männel, and R. S. Jack.
2001.
The essential role of lipopolysaccharide binding (LBP) in protection of mice against a peritoneal Salmonella infection involves the rapid induction of an inflammatory response.
J. Immunol.,
167:1624-1628[Abstract/Free Full Text].
|
| 10.
|
Hensler, T.,
C. D. Heidecke,
H. Hecker,
K. Heeg,
H. Bartels,
N. Zantl,
H. Wagner,
J. R. Siewert, and B. Holzmann.
1998.
Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production.
J. Immunol.
161:2655-2659[Abstract/Free Full Text].
|
| 11.
|
Huang, S.,
W. Hendriks,
A. Althage,
S. Hemmi,
H. Bluethmann,
R. Kamijo,
J. Vilcek,
R. M. Zinkernagel, and M. Aguet.
1993.
Immune response in mice that lack the interferon-gamma receptor.
Science
259:1742-1745[Abstract/Free Full Text].
|
| 12.
|
Jack, R. S.,
X. Fan,
M. Bernheiden,
G. Rune,
M. Ehlers,
A. Weber,
G. Kirsch,
R. Mentel,
B. Furll,
M. Freudenberg,
G. Schmitz,
F. Stelter, and C. Schütt.
1997.
Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
Nature
389:742-745[CrossRef][Medline].
|
| 13.
|
Katschinski, T.,
C. Galanos,
A. Coumbos, and M. A. Freudenberg.
1992.
Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice.
Infect. Immun.
60:1994-2001[Abstract/Free Full Text].
|
| 14.
|
Lauw, F. N.,
P. E. Dekkers,
A. A. te Velde,
P. Speelman,
M. Levi,
M. Kurimoto,
C. E. Hack,
S. J. van Deventer, and T. van der Poll.
1999.
Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees.
J. Infect. Dis.
179:646-652[CrossRef][Medline].
|
| 15.
|
Lucas, R.,
B. Echtenacher,
E. Sablon,
P. Juillard,
S. Magez,
J. Lou,
Y. Donati,
F. Bosman,
A. Van de Voorde,
L. Fransen,
D. N. Männel,
G. E. Grau, and P. de Baetselier.
1997.
Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.
Infect. Immun.
65:2006-2010[Abstract].
|
| 16.
|
Männel, D. N., and W. Falk.
1983.
Interferon-gamma is required in activation of macrophages for tumor cytotoxicity.
Cell. Immunol.
79:396-402[CrossRef][Medline].
|
| 17.
|
Mercer-Jones, M. A.,
M. Heinzelmann,
J. C. Peyton,
D. J. Wickel,
M. Cook, and W. G. Cheadle.
1997.
The pulmonary inflammatory response to experimental fecal peritonitis: relative roles of tumor necrosis factor-alpha and endotoxin.
Inflammation
21:401-417[CrossRef][Medline].
|
| 18.
|
Merlin, T.,
M. Gumenscheimer,
C. Galanos, and M. A. Freudenberg.
2001.
TNF- hyper-responses to gram-negative and gram-positive bacteria in Propionibacterium acnes-primed or Salmonella typhimurium infected mice.
J. Endotoxin Res.
7:157-163[CrossRef][Medline].
|
| 19.
|
Metzger, D. W.,
R. Raeder,
V. H. Van Cleave, and M. D. Boyle.
1995.
Protection of mice from group A streptococcal skin infection by interleukin-12.
J. Infect. Dis.
171:1643-1645[Medline].
|
| 20.
|
Miles, R. H.,
T. P. Paxton,
D. J. Dries, and R. L. Gamelli.
1994.
Interferon-gamma increases mortality following cecal ligation and puncture.
J. Trauma
36:607-611[Medline].
|
| 21.
|
O'Brien, A. D.,
D. L. Rosenstreich,
I. Scher,
G. H. Campbell,
R. P. MacDermott, and S. B. Formal.
1980.
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.
J. Immunol.
124:20-24[Medline].
|
| 22.
|
Poltorak, A.,
X. He,
I. Smirnova,
M. Y. Liu,
C. V. Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science
282:2085-2088[Abstract/Free Full Text].
|
| 23.
|
Schumann, R. R., and E. Latz.
2000.
Lipopolysaccharide-binding protein.
Chem. Immunol.
74:42-60[Medline].
|
| 24.
|
Spitalny, G. L., and E. A. Havell.
1984.
Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.
J. Exp. Med.
159:1560-1565[Abstract/Free Full Text].
|
| 25.
|
Steinhauser, M. L.,
C. M. Hogaboam,
N. W. Lukacs,
R. M. Strieter, and S. L. Kunkel.
1999.
Multiple roles for IL-12 in a model of acute septic peritonitis.
J. Immunol.
162:5437-5443[Abstract/Free Full Text].
|
| 26.
|
Takakuwa, T.,
H. P. Knopf,
A. Sing,
R. Carsetti,
C. Galanos, and M. A. Freudenberg.
1996.
Induction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice.
Eur. J. Immunol.
26:2686-2692[Medline].
|
| 27.
|
Takeuchi, O.,
K. Hoshino,
T. Kawai,
H. Sanjo,
H. Takada,
T. Ogawa,
K. Takeda, and S. Akira.
1999.
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
Immunity
11:443-451[CrossRef][Medline].
|
| 28.
|
Urbaschek, B.,
B. Ditter,
K. P. Becker, and R. Urbaschek.
1984.
Protective effects and role of endotoxin in experimental septicemia.
Circ. Shock
14:209-222[Medline].
|
| 29.
|
von Jeney, N.,
E. Günther, and K. Jann.
1977.
Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection.
Infect. Immun.
15:26-33[Abstract/Free Full Text].
|
| 30.
|
Wysocka, M.,
M. Kubin,
L. Q. Vieira,
L. Ozmen,
G. Garotta,
P. Scott, and G. Trinchieri.
1995.
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
Eur. J. Immunol.
25:672-676[Medline].
|
| 31.
|
Zantl, N.,
A. Uebe,
B. Neumann,
H. Wagner,
J. R. Siewert,
B. Holzmann,
C. D. Heidecke, and K. Pfeffer.
1998.
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.
Infect. Immun.
66:2300-2309[Abstract/Free Full Text].
|
| 32.
|
Zhou, P.,
M. C. Sieve,
J. Bennett,
K. J. Kwon-Chung,
R. P. Tewari,
R. T. Gazzinelli,
A. Sher, and R. A. Seder.
1995.
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma.
J. Immunol.
155:785-795[Abstract].
|
| 33.
|
Zisman, D. A.,
S. L. Kunkel,
R. M. Strieter,
J. Gauldie,
W. C. Tsai,
J. Bramson,
J. M. Wilkowski,
K. A. Bucknell, and T. J. Standiford.
1997.
Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.
Shock
8:349-356[Medline].
|
Infection and Immunity, December 2001, p. 7271-7276, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7172-7276.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Etogo, A. O., Nunez, J., Lin, C. Y., Toliver-Kinsky, T. E., Sherwood, E. R.
(2008). NK but Not CD1-Restricted NKT Cells Facilitate Systemic Inflammation during Polymicrobial Intra-Abdominal Sepsis. J. Immunol.
180: 6334-6345
[Abstract]
[Full Text]
-
Nakano, N., Nishiyama, C., Kanada, S., Niwa, Y., Shimokawa, N., Ushio, H., Nishiyama, M., Okumura, K., Ogawa, H.
(2007). Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood
109: 4846-4855
[Abstract]
[Full Text]
-
Berbee, J. F. P., van der Hoogt, C. C., Kleemann, R., Schippers, E. F., Kitchens, R. L., van Dissel, J. T., Bakker-Woudenberg, I. A. J. M., Havekes, L. M., Rensen, P. C. N.
(2006). Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J.
20: 2162-2164
[Abstract]
[Full Text]
-
Moreno, S. E., Alves-Filho, J. C., Alfaya, T. M., da Silva, J. S., Ferreira, S. H., Liew, F. Y.
(2006). IL-12, but Not IL-18, Is Critical to Neutrophil Activation and Resistance to Polymicrobial Sepsis Induced by Cecal Ligation and Puncture.. J. Immunol.
177: 3218-3224
[Abstract]
[Full Text]
-
Nemeth, Z. H., Csoka, B., Wilmanski, J., Xu, D., Lu, Q., Ledent, C., Deitch, E. A., Pacher, P., Spolarics, Z., Hasko, G.
(2006). Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis. J. Immunol.
176: 5616-5626
[Abstract]
[Full Text]
-
Flohe, S. B., Agrawal, H., Schmitz, D., Gertz, M., Flohe, S., Schade, F. U.
(2006). Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. J. Leukoc. Biol.
79: 473-481
[Abstract]
[Full Text]
-
Kitchens, R. L., Thompson, P. A.
(2005). Modulatory effects of sCD14 and LBP on LPS-host cell interactions. Innate Immunity
11: 225-229
[Abstract]
-
Ness, T. L., Carpenter, K. J., Ewing, J. L., Gerard, C. J., Hogaboam, C. M., Kunkel, S. L.
(2004). CCR1 and CC Chemokine Ligand 5 Interactions Exacerbate Innate Immune Responses during Sepsis. J. Immunol.
173: 6938-6948
[Abstract]
[Full Text]
-
Hargrave, S. L., Hay, C., Mellon, J., Mayhew, E., Niederkorn, J. Y.
(2004). Fate of MHC-Matched Corneal Allografts in Th1-Deficient Hosts. IOVS
45: 1188-1193
[Abstract]
[Full Text]
-
Sherwood, E. R., Lin, C. Y., Tao, W., Hartmann, C. A., Dujon, J. E., French, A. J., Varma, T. K.
(2003). {beta}2 Microglobulin Knockout Mice Are Resistant to Lethal Intraabdominal Sepsis. Am. J. Respir. Crit. Care Med.
167: 1641-1649
[Abstract]
[Full Text]
-
Gold, J. A., Parsey, M., Hoshino, Y., Hoshino, S., Nolan, A., Yee, H., Tse, D. B., Weiden, M. D.
(2003). CD40 Contributes to Lethality in Acute Sepsis: In Vivo Role for CD40 in Innate Immunity. Infect. Immun.
71: 3521-3528
[Abstract]
[Full Text]
-
Opal, S. M.
(2002). The clinical relevance of endotoxin in human sepsis: a critical analysis. Innate Immunity
8: 473-476
[Abstract]
-
Echtenacher, B., Mannel, D. N.
(2002). Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. Innate Immunity
8: 365-369
[Abstract]